FLEX PHARMA INC's ticker is FLKS and the CUSIP is 33938A105. A total of 27 filers reported holding FLEX PHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $5,000 | +25.0% | 12,394 | -1.9% | 0.00% | – |
| Q4 2018 | $4,000 | -33.3% | 12,639 | 0.0% | 0.00% | – |
| Q3 2018 | $6,000 | -50.0% | 12,639 | -0.4% | 0.00% | – |
| Q2 2018 | $12,000 | -84.2% | 12,689 | -15.9% | 0.00% | – |
| Q1 2018 | $76,000 | +72.7% | 15,093 | +18.5% | 0.00% | – |
| Q4 2017 | $44,000 | -2.2% | 12,739 | -3.5% | 0.00% | – |
| Q3 2017 | $45,000 | -10.0% | 13,199 | 0.0% | 0.00% | – |
| Q2 2017 | $50,000 | -73.0% | 13,199 | -68.6% | 0.00% | – |
| Q1 2017 | $185,000 | -15.9% | 42,053 | +1.2% | 0.00% | – |
| Q4 2016 | $220,000 | -53.7% | 41,566 | +3.1% | 0.00% | – |
| Q3 2016 | $475,000 | +12.6% | 40,310 | -2.4% | 0.00% | – |
| Q2 2016 | $422,000 | +24.1% | 41,313 | +33.2% | 0.00% | – |
| Q1 2016 | $340,000 | -31.7% | 31,016 | -22.4% | 0.00% | – |
| Q4 2015 | $498,000 | +18.3% | 39,954 | +14.1% | 0.00% | – |
| Q3 2015 | $421,000 | -26.9% | 35,030 | +4.6% | 0.00% | – |
| Q2 2015 | $576,000 | +3.4% | 33,484 | +17.9% | 0.00% | – |
| Q1 2015 | $557,000 | – | 28,401 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 933,691 | $11,214,000 | 5.10% |
| ACUTA CAPITAL PARTNERS, LLC | 88,716 | $1,065,000 | 0.62% |
| PURA VIDA INVESTMENTS, LLC | 72,000 | $865,000 | 0.49% |
| Lombard Odier Asset Management (USA) Corp | 109,084 | $1,310,000 | 0.11% |
| Tekla Capital Management LLC | 232,600 | $2,794,000 | 0.10% |
| Abingworth LLP | 10,000 | $120,000 | 0.07% |
| Nicholas Investment Partners, LP | 56,601 | $680,000 | 0.05% |
| C WorldWide Group Holding A/S | 71,700 | $756,000 | 0.01% |
| JENNISON ASSOCIATES LLC | 656,651 | $7,886,000 | 0.01% |
| VANGUARD GROUP INC | 4,654,700 | $146,091,000 | 0.01% |